GM23929
LCL from B-Lymphocyte
Description:
NEMALINE MYOPATHY 2, AUTOSOMAL RECESSIVE; NEM2
NEBULIN; NEB
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Muscular Dystrophies
CMD Specific |
| Class |
Congenital Muscle Diseases |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Ethnicity
|
Irish, German, Polish
|
|
Country of Origin
|
USA
|
|
Family Member
|
1
|
|
Family History
|
N
|
|
Relation to Proband
|
proband
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
NEB |
| Chromosomal Location |
2q23.3 |
| Allelic Variant 1 |
p.Trp5885*; NEMALINE MYOPATHY 2 (NEM2) |
| Identified Mutation |
c.17654G>A |
| |
| Gene |
NEB |
| Chromosomal Location |
2q23.3 |
| Allelic Variant 2 |
p.Phe8257Leufs*10; NEMALINE MYOPATHY 2 (NEM2) |
| Identified Mutation |
c.24771delT |
| Remarks |
Clinically affected; exome sequencing of exons 112 and 176 revealed subject has two mutations in the NEB gene: c.17654G>A (p.Trp5885*), a known causative mutation resulting in a premature protein termination; and c.24771delT (p.Phe8257Leufs*10), a mutation predicted to result in a frame-shift and premature protein termination; family history: maternal first cousin once removed is also affected (not in repository). |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|